Engineering Regulatory T Cells With TCR-Signaling-Responsive Interleukin 2 Nanoparticles Provides In Situ Suppression Of Alloimmunity.S. K. Eskandari,M. B. Melo,I. Sulkaj, N. Li,S. Cai,H. Allos,J. Y. Choi,D. J. Irvine,J. R. AzziAMERICAN JOURNAL OF TRANSPLANTATION（2019）引用 1|浏览1暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
